Neurotensin is a tridecapeptide originally identified in extracts of bovine hypothalamus. This peptide has a close anatomical and functional relationship with the mesocorticolimbic and nigrostriatal dopamine system. Neural circuits containing neurotensin were originally proposed to play a role in the mechanism of action of antipsychotic agents. Additionally, neurotensin-containing pathways were demonstrated to mediate some of the rewarding and/or sensitizing properties of drugs of abuse.This review attempts to contribute to the understanding of the role of neurotensin and its receptors in drug abuse. In particular, we will summarize the potential relevance of neurotensin, its related compounds and neurotensin receptors in substance use disorders, with a focus on the preclinical research.

Neurotensin: A role in substance use disorder?

FERRARO, Luca Nicola
Primo
;
TIOZZO FASIOLO, Laura
Secondo
;
BEGGIATO, Sarah;BORELLI, Andrea Celeste;ANTONELLI, Tiziana;TOMASINI, Maria Cristina;
2016

Abstract

Neurotensin is a tridecapeptide originally identified in extracts of bovine hypothalamus. This peptide has a close anatomical and functional relationship with the mesocorticolimbic and nigrostriatal dopamine system. Neural circuits containing neurotensin were originally proposed to play a role in the mechanism of action of antipsychotic agents. Additionally, neurotensin-containing pathways were demonstrated to mediate some of the rewarding and/or sensitizing properties of drugs of abuse.This review attempts to contribute to the understanding of the role of neurotensin and its receptors in drug abuse. In particular, we will summarize the potential relevance of neurotensin, its related compounds and neurotensin receptors in substance use disorders, with a focus on the preclinical research.
2016
Ferraro, Luca Nicola; TIOZZO FASIOLO, Laura; Beggiato, Sarah; Borelli, Andrea Celeste; Pomierny Chamiolo, L; Frankowska, M; Antonelli, Tiziana; Tomasini, Maria Cristina; Fuxe, K; Filip, M.
File in questo prodotto:
File Dimensione Formato  
J Psychopharmacol-2016-Ferraro-112-27 (2).pdf

solo gestori archivio

Descrizione: versione editoriale
Tipologia: Full text (versione editoriale)
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 603.46 kB
Formato Adobe PDF
603.46 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Preprint11392-2351557.pdf

accesso aperto

Descrizione: versione preprint
Tipologia: Pre-print
Licenza: PUBBLICO - Pubblico con Copyright
Dimensione 322.93 kB
Formato Adobe PDF
322.93 kB Adobe PDF Visualizza/Apri

I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/2351557
Citazioni
  • ???jsp.display-item.citation.pmc??? 20
  • Scopus 32
  • ???jsp.display-item.citation.isi??? 31
social impact